In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Biotin Dermapharm Brand Drug Master File in Korea (Biotin Dermapharm Brand KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Biotin Dermapharm Brand. The MFDS reviews the Biotin Dermapharm Brand KDMF as part of the drug registration process and uses the information provided in the Biotin Dermapharm Brand KDMF to evaluate the safety and efficacy of the drug.
After submitting a Biotin Dermapharm Brand KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Biotin Dermapharm Brand API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Biotin Dermapharm Brand suppliers with KDMF on PharmaCompass.